期刊
JOURNAL OF INVESTIGATIVE DERMATOLOGY
卷 131, 期 4, 页码 944-955出版社
ELSEVIER SCIENCE INC
DOI: 10.1038/jid.2010.377
关键词
-
类别
资金
- Interdisciplinary Center of Clinical Research (IZKF) [Lo2/017/07]
- German Cancer Society [107891]
- German Research Association (DFG) [Lo817/2-1]
Melanoma accounts for similar to 79% of skin cancer-related deaths, and the receptor activator of NF-kappa B (RANK)-receptor activator of NF-kappa B ligand (RANKL) pathway has been shown to be involved in the migration and metastasis of epithelial tumor cells. In this study, we demonstrate that RANK was significantly increased in peripheral circulating melanoma cells, primary melanomas, and metastases from stage IV melanoma patients compared with tumor cells from stage I melanoma patients. However, upregulated RANK expression was not found in stage IV melanoma patients with bone metastases compared with stage IV melanoma patients without bone metastases, providing a possible explanation for the clinical observation that melanoma cells do not preferentially metastasize to bone tissue. Strikingly, RANK-expressing melanoma cells from peripheral blood, primary tumors, or metastases of stage IV patients coexpressed ATP-binding cassette (ABC) B5 and CD133, both markers characteristic of melanoma-initiating cells, suggesting a tumor stem cell-like phenotype. In support of this hypothesis, RANK-expressing melanoma cells showed a reduced Ki67 proliferation index compared with RANK(-) melanoma cells from the same patient and are able to induce tumor growth in immunodeficient mice. Together, our data demonstrate that RANK expression is increased in metastatic melanoma and highly upregulated on melanoma-initiating cells, suggesting that RANK might be involved in the development and maintenance of melanoma-initiating cells and possibly in metastatic spreading. Journal of Investigative Dermatology (2011) 131, 944-955; doi:10.1038/jid.2010.377; published online 27 January 2011
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据